BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9812730)

  • 1. [Effects of oxymatrine on arrhythmia in dogs with myocardial infarction].
    Zeng JX; Cao HY; Li Q; Xu Z; Guo ZB
    Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):379-82. PubMed ID: 9812730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia].
    Guo ZB; Cao HY; Xu Z; Li Q
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):44-7. PubMed ID: 1950584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias].
    Guo Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Apr; 20(2):119-22, 134. PubMed ID: 1473481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effects of berberine on spontaneous ventricular fibrillation in dogs after myocardial infarction].
    Xu Z; Cao HY; Li Q
    Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):320-4. PubMed ID: 2624115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-arrhythmic effects of sophoridine and oxysophoridine.
    Zhang HM; Li HQ
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):517-20. PubMed ID: 10678144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
    Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
    Zuanetti G; Corr PB
    J Pharmacol Exp Ther; 1991 Jan; 256(1):325-34. PubMed ID: 1988663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.
    D'Alonzo AJ; Sewter JC; Darbenzio RB; Hess TA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):222-8. PubMed ID: 7477447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective and anti-arrhythmic effects of dauricine and verapamil on acute myocardial infarction in anesthetized dogs.
    Zhu JQ; Zeng FD; Hu CJ
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):249-51. PubMed ID: 1442108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic denervation of the epicardial border zone in the genesis of dispersion of refractoriness and arrhythmogenesis in a 7-day-old canine myocardial infarction model.
    Saeki K; Ogawa S; Sadanaga T; Yoh S; Furuno I; Nakamura Y
    Coron Artery Dis; 1993 Sep; 4(9):775-82. PubMed ID: 8287211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes.
    Yamamoto K; Bando S
    Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic effect of ethyl acetate extract from Chrysanthemum Morifolium Ramat on rats].
    ZHANG W; YE ZG; CUI J; QIU SF; XU WH; WANG HP; QIAN LB; JIANG HD; XIA Q
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):377-82. PubMed ID: 19693975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant prolongation of the refractory period and repolarization time by a class III agent, E4031, in the healing phase of myocardial infarction.
    Takatsuki S; Mitamura H; Sueyoshi K; Kanki H; Furuno I; Ogawa S
    Jpn Heart J; 1998 Sep; 39(5):687-97. PubMed ID: 9926000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of left ventricular systolic pressure increase on ventricular arrhythmogenicity in old canine myocardial infarction.
    Yano K; Hano O; Hirata T; Matsumoto Y; Hirata M; Mitsuoka T
    Cardiovasc Res; 1992 Oct; 26(10):988-93. PubMed ID: 1486594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction.
    Denniss AR; Richards DA; Taylor AT; Uther JB
    Basic Res Cardiol; 1989; 84(1):5-12. PubMed ID: 2923606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
    Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.